| Financial Year |
March 31 2023 |
| Monetary Funds |
1,071,540,375.63 |
| Held-for-trading Financial Assets |
33,085,870.61 |
| Notes Receivable |
115,000.00 |
| Accounts Receivable |
253,931,867.80 |
| Advances to Suppliers |
118,245,906.22 |
| Other Receivables |
17,337,652.88 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
286,555,303.28 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
25,781,032.01 |
| Total Current Assets |
1,806,593,008.43 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
783,042,556.76 |
| Under-construction Projects |
304,414,016.51 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
100,900,002.33 |
| R&D expenses |
-- |
| Goodwill |
2,130,742.12 |
| Long-Term Deferred and Prepaid Expenses |
53,343.23 |
| Deferred Income Tax Assets |
6,024,176.13 |
| Other Non-Current Assets |
244,318,639.04 |
| Sub-Total of Non-Current Assets |
1,445,653,258.70 |
| Total Assets |
3,252,246,267.13 |
| Short-Term Loans |
724,742,617.86 |
| Trading Financial liabilities |
163,340.19 |
| Notes Payable |
-- |
| Accounts Payable |
196,046,011.95 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
35,569,908.17 |
| Taxes Payable |
7,412,662.41 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
49,561,064.67 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
4,028,594.88 |
| Other Current Liabilities |
1,353,827.19 |
| Sub-Total of Current Liabilities |
1,064,078,025.05 |
| Long-term Loans |
52,871,087.64 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
4,870,348.45 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
31,544,743.19 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
103,215,292.13 |
| Total Liabilities |
1,167,293,317.18 |
| Paid-In Capital(Or Share Stock) |
134,627,593.00 |
| Capital Surplus |
836,244,926.83 |
| Surplus Reserve |
87,734,629.05 |
| LESS:Treasury Stock |
45,784,870.00 |
| Undistributed Profits |
1,082,103,429.87 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,084,952,949.95 |
| Owner's Equity（Stockholder's Equity） |
2,084,952,949.95 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,252,246,267.13 |
